Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation-Reference-Cited by-同舟云学术

Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation

Published:2021-03-19 Issue:4 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Higgins Victoria¹^ORCID,Fabros Anselmo²,Kulasingam Vathany¹²^ORCID

Affiliation:

1. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

2. Division of Clinical Biochemistry, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). While molecular-based testing is used to diagnose COVID-19, serologic testing of antibodies specific to SARS-CoV-2 is used to detect past infection.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.03149-20

Reference14 articles.

1. Assay Techniques and Test Development for COVID-19 Diagnosis

2. SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health

3. Antibody tests for identification of current and past infection with SARS-CoV-2

4. Antibody responses to SARS-CoV-2 in patients with COVID-19

5. Ten reasons why immunity passports are a bad idea

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy;Journal of Clinical Virology;2024-08

2. Seroprevalence of SARS-CoV-2 IgG in blood donors in a teaching institute from Western part of Maharashtra;Journal of Family Medicine and Primary Care;2024-05

3. Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis;The Lancet Microbe;2024-03

4. Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea;Frontiers in Immunology;2023-12-20

5. Effects of Antibodies in the Serum After the Administration of COVID Vaccines and Their Hematological and Cardiovascular Complications;Cureus;2023-10-30